{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T23:32:30Z","timestamp":1777332750499,"version":"3.51.4"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Res Ther"],"DOI":"10.1186\/s12981-026-00871-8","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T17:24:31Z","timestamp":1773854671000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pre-conflict prescription patterns and virological effectiveness of combination antiretroviral therapy (cART) in HIV-1 patients in Tigray, Ethiopia"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2516-4680","authenticated-orcid":false,"given":"Gebrecherkos Teame","family":"Gebrehiwot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gebreselema","family":"Gebreyohannes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mulugeta","family":"Tilahun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ataklti","family":"Gessese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mebrahatom","family":"Gebrelibanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goyitom","family":"Gebremedhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kibriti Mehari","family":"Kidane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haileselassie Bisrat","family":"Bidre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goitom","family":"Yisfa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mebrahtu","family":"Kalayou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kebede","family":"Araya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etsay Weldekidan","family":"Tsegay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yemane Tadesse","family":"Desta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mebrahtu Teweldemedhin","family":"Shfare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayelom","family":"Kahsay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"1","key":"871_CR1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.2174\/1874613601610010034","volume":"10","author":"ABM Kharsany","year":"2016","unstructured":"Kharsany ABM, Karim QA. HIV Infection and AIDS in Sub-Saharan Africa: Current Status, Challenges and Opportunities. Open AIDS J. 2016;10(1):34\u201348.","journal-title":"Open AIDS J"},{"key":"871_CR2","unstructured":"UNAIDS, Global HIV. & AIDS statistics \u2014 Fact sheet. https:\/\/www.unaids.org\/en\/resources\/fact-sheet"},{"key":"871_CR3","doi-asserted-by":"crossref","unstructured":"Department of Microbiology, University of Nigeria, Nsukka, Nigeria, Amuche NJ, Emmanuel EI, Department of Microbiology, University of Nigeria, Nsukka, Nigeria, Innocent NE. Department of Microbiology, University of Nigeria, Nsukka, Nigeria. HIV\/AIDS in sub-Saharan Africa: Current status, challenges and prospects. Asian Pac J Trop Dis. 2017;7(4):239\u201356.","DOI":"10.12980\/apjtd.7.2017D6-366"},{"key":"871_CR4","unstructured":"Joint United Nations Programme on HIV\/AIDS. 2023. Amplifying successes towards ending AIDS: Case studies from eastern and southern Africa. Geneva. Report No.: CC BY-NC-SA 3.0 IGO."},{"key":"871_CR5","unstructured":"Ethiopian Public Health Institute. HIV Related Estimates and Projections in Ethiopia for the Year 2023\u20132024. https:\/\/ephi.gov.et\/wp-content\/uploads\/2024\/07\/HIV-Estimates-and-projection-for-the-year-2023-and-2024-EPHI-Infectiouse-Disease-Research-Directorete-July052024.pdf"},{"issue":"11","key":"871_CR6","first-page":"1","volume":"17","author":"AG Teka","year":"2023","unstructured":"Teka AG, Gebregzabiher E, Atsbaha AH, Woldu M, Ataklti G, Gebretinssae H, et al. Prevalence of HIV and Trends of ART Utilization among Key and Priority Population in Tigray Regional State, Northern Ethiopia, 2019. Ealth Sci J. 2023;17(11):1\u201310.","journal-title":"Ealth Sci J"},{"key":"871_CR7","doi-asserted-by":"crossref","unstructured":"Weledegebriel MG, Abebe HT, Gidey K, Bisrat H, Gebru T, Tsegay N et al. The impact of war on HIV\/AIDS service provision: In rural health facilities of Tigray, northern Ethiopia, a cross-sectional study. Ali MM, editor. PLOS ONE. 2023;18(5): e0278976.","DOI":"10.1371\/journal.pone.0278976"},{"key":"871_CR8","doi-asserted-by":"crossref","unstructured":"Kerschberger B, Jobanputra K, Schomaker M, Kabore SM, Teck R, Mabhena E et al. Feasibility of antiretroviral therapy initiation under the treat-all policy under routine conditions: a prospective cohort study from Eswatini. J Int AIDS Soc. 2019. 22(10).","DOI":"10.1002\/jia2.25401"},{"key":"871_CR9","unstructured":"WHO.HIV data and statistics. https:\/\/www.who.int\/teams\/global-hivhepatitis-and-stis-programmes\/hiv\/strategic-information\/hiv-data & statistics#:~:text\u2009=\u2009In%202023%2\u00a0C%2030.7%20million%20people,status%20and%20access%20antiretroviral%20therapy."},{"issue":"2","key":"871_CR10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0753-3322(99)80063-8","volume":"53","author":"RW Shafer","year":"1999","unstructured":"Shafer RW, Vuitton DA. Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1. Biomed Pharma other. 1999;53(2):73\u201386.","journal-title":"Biomed Pharma other"},{"key":"871_CR11","unstructured":"Eggleton JS, Nagalli S. Highly Active Antiretroviral Therapy (HAART). In: Stat Pearls. Treasure Island (FL): Stat Pearls Publishing; 2025. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK554533\/. Accessed 1 May 2025"},{"issue":"2","key":"871_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/hiv.13346","volume":"24","author":"S Carvalho","year":"2023","unstructured":"Carvalho S, Lee T, Tulloch KJ, Sauve LJ, Samson L, Brophy JC, et al. Prescribing patterns of antiretroviral treatments during pregnancy for women living with HIV in Canada 2004\u20132020: A surveillance study. HIV Med. 2023. 24(2):130\u20138.","journal-title":"HIV Med"},{"key":"871_CR13","doi-asserted-by":"crossref","unstructured":"Tegegne AS, Zeru MA. Evaluation of the interventions on HIV case management and its association with cART adherence and disclosure of the disease status among HIV-positive adults under treatment. Sci Rep. 2022.https:\/\/www.nature.com\/articles\/s41598-022-17905-6. Accessed 1 May 2025.","DOI":"10.1038\/s41598-022-17905-6"},{"issue":"11","key":"871_CR14","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1080\/17460441.2023.2246872","volume":"18","author":"S Xu","year":"2023","unstructured":"Xu S, Sun L, Liu X, Zhan P. Opportunities and challenges in new HIV therapeutic discovery: what is the next step? Expert Opin Drug Discov. 2023;18(11):1195\u20139.","journal-title":"Expert Opin Drug Discov"},{"key":"871_CR15","doi-asserted-by":"publisher","unstructured":"Chicanequisso EM, Baltazar CS, Sacarlal J. Clinical-epidemiological profile and factors associated with viral non-suppression in patients living with HIV\/AIDS assisted at the Integrated Treatment Center at the Maputo Military Hospital (CITRA\/MMH), 2019 to 2020. BMC Infect Dis. 2024. https:\/\/bmcinfectdis.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12879-024-09616-2. Accessed 1 May 2025.","DOI":"10.1186\/s12879-024-09616-2"},{"key":"871_CR16","doi-asserted-by":"publisher","unstructured":"Shiferaw MB, Endalamaw D, Hussien M, Agegne M, Amare D, Estifanos F et al. Viral suppression rate among children tested for HIV viral load at the Amhara Public Health Institute, Bahir Dar, Ethiopia. BMC Infect Dis. 2019. https:\/\/bmcinfectdis.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12879-019-4058-4. Accesed 1 May 2025.","DOI":"10.1186\/s12879-019-4058-4"},{"issue":"3","key":"871_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.farma.2023.12.005","volume":"48","author":"E Contreras-Mac\u00edas","year":"2024","unstructured":"Contreras-Mac\u00edas E, Guti\u00e9rrez-Pizarraya A, Pineda-Vergara JA, Morillo-Verdugo R. Analysis of antiretroviral therapy interruption in people living with HIV during the 2010\u20132021 period. Farm Hosp. 2024. 48(3):101\u20137.","journal-title":"Farm Hosp"},{"key":"871_CR18","doi-asserted-by":"crossref","unstructured":"Ford N, Patten G, Rangaraj A, Davies MA, Meintjes G, Ellman T. Outcomes of people living with HIV after hospital discharge: a systematic review and meta-analysis. Lancet HIV. 2022 mar;9(3):e150\u20139.","DOI":"10.1016\/S2352-3018(21)00329-5"},{"key":"871_CR19","doi-asserted-by":"publisher","first-page":"101243","DOI":"10.1016\/j.lanepe.2025.101243","volume":"52","author":"M Parczewski","year":"2025","unstructured":"Parczewski M, G\u00f6kengin D, Sullivan A, De Amo J, Cairns G, Bivol S, et al. Control of HIV across the WHO European region: progress and remaining challenges. Lancet Reg Health - Eur. 2025;52:101243.","journal-title":"Lancet Reg Health - Eur"},{"issue":"12","key":"871_CR20","doi-asserted-by":"publisher","first-page":"e861","DOI":"10.1016\/S2352-3018(24)00233-9","volume":"11","author":"CP Cortes","year":"2024","unstructured":"Cortes CP, Sued O, Wong WCW, Borquez A, Ssonko C, Parczewski M, et al. Humanising and optimizing HIV health care for refugees and asylum seekers. Lancet HIV. 2024;11(12):e861\u201372.","journal-title":"Lancet HIV"},{"key":"871_CR21","unstructured":"World Health Organization. Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis, and recommendations on early infant diagnosis of HIV. https:\/\/www.who.int\/publications\/i\/item\/WHO-CDS-HIV-18.51#:~:text=Overview,for%20children%2C%20adolescents%20and%20adults"},{"issue":"1","key":"871_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12985-025-02828-1","volume":"22","author":"GT Gebrehiwot","year":"2025","unstructured":"Gebrehiwot GT, Tilahun M, Gebreyohannes G, Gessese A, Bisrat H, Weldegiorgis D, Amare T, Assefa F, Alemseged G, Alemseged G, Kahsay H. A retrospective study on HIV virological recovery patterns and factors associated with HIV viral treatment using highly active antiretroviral therapy (HAART) in public health facilities in Tigray, Northern Ethiopia. Virol J. 2025;22(1):317.","journal-title":"Virol J"},{"key":"871_CR23","doi-asserted-by":"crossref","unstructured":"Fentie Wendie T, Workneh BD. Prevalence and Predictors of Virological Failure Among Adults Living with HIV in South Wollo Zone, Northeast Ethiopia: A Retrospective Cohort Study. Volume 12. HIVAIDS Auckland, NZ.; 2020. pp. 393\u2013402.","DOI":"10.2147\/HIV.S266460"},{"issue":"1","key":"871_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5530\/jyp.2018.10.26","volume":"10","author":"JP Modi","year":"2018","unstructured":"Modi JP, Kubavat A, Mundhava S, Lalwani U. A Prospective Study to Evaluate Prescription Pattern of Second Line Antiretroviral Therapy Given to HIV Patients. J Young Pharm. 2018;10(1):117\u201322.","journal-title":"J Young Pharm"},{"issue":"S4","key":"871_CR25","first-page":"1","volume":"15","author":"A Ammassari","year":"2012","unstructured":"Ammassari A, Angeletti C, Murachelli S, Girardi E, Antinori A. Prescription patterns and costs of antiretroviral therapy in HIV-infected na\u00efve patients: theoretical impact of a regional therapeutic protocol. J Int AIDS Soc. 2012;15(S4):1\u20131.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"871_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13690-018-0299-8","volume":"76","author":"T Girum","year":"2018","unstructured":"Girum T, Wasie A, Lentiro K, Muktar E, Shumbej T, Difer M, et al. Gender disparity in epidemiological trend of HIV\/AIDS infection and treatment in Ethiopia. Arch Public Health. 2018;76(1):51.","journal-title":"Arch Public Health"},{"issue":"9","key":"871_CR27","doi-asserted-by":"publisher","first-page":"e1001304","DOI":"10.1371\/journal.pmed.1001304","volume":"9","author":"M Cornell","year":"2012","unstructured":"Cornell M, Schomaker M, Garone DB, Giddy J, Hoffmann CJ, Lessells R, et al. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicenter cohort study. PLoS Med. 2012;9(9):e1001304.","journal-title":"PLoS Med"},{"issue":"1","key":"871_CR28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1089\/jwh.2007.0353","volume":"17","author":"P Braitstein","year":"2008","unstructured":"Braitstein P, Boulle A, Nash D, Brinkhof MWG, Dabis F, Laurent C, et al. Gender and the Use of Antiretroviral Treatment in Resource-Constrained Settings: Findings from a Multicenter Collaboration. J Women Health. 2008;17(1):47\u201355.","journal-title":"J Women Health"},{"key":"871_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijid.2020.05.097","volume":"97","author":"EK Maina","year":"2020","unstructured":"Maina EK, Mureithi H, Adan AA, Muriuki J, Lwembe RM, Bukusi EA. Incidents and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya. Int J Infect Dis. 2020;97:151\u20138.","journal-title":"Int J Infect Dis"},{"key":"871_CR30","doi-asserted-by":"crossref","unstructured":"Chachu KH, Maboe KA. Viral suppression among patients in HIV\/AIDS care at healthcare facilities in Ethiopia: Same-day antiretroviral initiation. Kose J, editor. PLOS ONE. 2025;20(2): e0309579.","DOI":"10.1371\/journal.pone.0309579"},{"key":"871_CR31","doi-asserted-by":"crossref","unstructured":"Gebre Meles H, Temesgen H, Alemayehu M. CD4 Count Progression of Adult HIV Patients Under ART Follow-Up at Mekelle General Hospital, Tigray Region: A Longitudinal Data Analysis Approach. Epidemiol Biostat Public Health. 2022. https:\/\/riviste.unimi.it\/index.php\/ebph\/article\/view\/17164. Accessed 26 Apr 2025.","DOI":"10.2427\/13234"},{"issue":"1","key":"871_CR32","doi-asserted-by":"publisher","first-page":"e068792","DOI":"10.1136\/bmjopen-2022-068792","volume":"13","author":"H Berihun","year":"2023","unstructured":"Berihun H, Bazie GW, Beyene A, Zewdie A, Kebede N. Viral suppression and associated factors among children tested for HIV viral load at Amhara Public Health Institute, Dessie Branch, Ethiopia: a cross-sectional study. BMJ Open. 2023;13(1):e068792.","journal-title":"BMJ Open"},{"issue":"1","key":"871_CR33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12981-023-00523-1","volume":"20","author":"MB Chagomerana","year":"2023","unstructured":"Chagomerana MB, Harrington BJ, DiPrete BL, Wallie S, Maliwichi M, Wesevich A, et al. Three-year outcomes for women newly initiated on lifelong antiretroviral therapy during pregnancy \u2013 Malawi option B+. AIDS Res Ther. 2023;20(1):37.","journal-title":"AIDS Res Ther"},{"issue":"Suppl 5","key":"871_CR34","first-page":"e25550","volume":"23","author":"R Niyonsenga","year":"2020","unstructured":"Niyonsenga R, Nkunda R, Habiyambere V, et al. Viral suppression among people living with HIV in Rwanda: outcomes from the national HIV care and treatment program. J Int AIDS Soc. 2020;23(Suppl 5):e25550.","journal-title":"J Int AIDS Soc"},{"key":"871_CR35","doi-asserted-by":"crossref","unstructured":"Lefrancois LH, Nguyen BT, Pham TTP, Le NTH, Dao HTT, Tran TH et al. Assessment of HIV viral load monitoring in remote settings in Vietnam - comparing people who inject drugs to the other patients. Nelson JA, editor. PLOS ONE. 2023;18(2): e0281857.","DOI":"10.1371\/journal.pone.0281857"},{"issue":"1","key":"871_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1742-6405-7-39","volume":"7","author":"A Tiyou","year":"2010","unstructured":"Tiyou A, Belachew T, Alemseged F, Biadgilign S. Predictors of adherence to antiretroviral therapy among people living with HIV\/AIDS in the resource-limited setting of southwest Ethiopia. AIDS Res Ther. 2010;7(1):39.","journal-title":"AIDS Res Ther"},{"key":"871_CR37","doi-asserted-by":"crossref","unstructured":"Mitiku H, Abdosh T, Teklemariam Z. Factors Affecting Adherence to Antiretroviral Treatment in Harari National Regional State, Eastern Ethiopia. ISRN AIDS. 2013; 2013:1\u20137.","DOI":"10.1155\/2013\/960954"},{"key":"871_CR38","doi-asserted-by":"crossref","unstructured":"Kioko MT, Pertet AM. Factors contributing to antiretroviral drug adherence among adults living with HIV or AIDS in a Kenyan rural community. Afr J Prim Health Care Fam Med. 2017. https:\/\/phcfm.org\/index.php\/phcfm\/article\/view\/1343. Accessed 25 Apr 2025.","DOI":"10.4102\/phcfm.v9i1.1343"},{"issue":"10","key":"871_CR39","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1089\/aid.2004.20.1053","volume":"20","author":"JB Nachega","year":"2004","unstructured":"Nachega JB, Stein DM, Lehman DA, Hlatshwayo D, Mothopeng R, Chaisson RE, et al. Adherence to Antiretroviral Therapy in HIV-Infected Adults in Soweto, South Africa. AIDS Res Hum Retroviruses. 2004;20(10):1053\u20136.","journal-title":"AIDS Res Hum Retroviruses"},{"key":"871_CR40","doi-asserted-by":"crossref","unstructured":"Luoga E, Okuma J, Moshi L, Sigalla G, Mnzava D, Paris DH et al. Viral suppression and adherence in adolescents living with HIV in rural Tanzania. Misganie YG, editor. PLOS ONE. 2024;19(12): e0315866.","DOI":"10.1371\/journal.pone.0315866"},{"issue":"2","key":"871_CR41","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/1359105307074298","volume":"12","author":"JT Parsons","year":"2007","unstructured":"Parsons JT, Rosof E, Mustanski B. Patient-related Factors Predicting HIV Medication Adherence among Men and Women with Alcohol Problems. J Health Psychol. 2007;12(2):357\u201370.","journal-title":"J Health Psychol"},{"issue":"3","key":"871_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/00126334-200311010-00004","volume":"34","author":"S Weiser","year":"2003","unstructured":"Weiser S, Wolfe W, Bangsberg D, Thior I, Gilbert P, Makhema J, et al. Barriers to Antiretroviral Adherence for Patients Living with HIV Infection and AIDS in Botswana. JAIDS J Acquir Immune Defic Syndr. 2003;34(3):281\u20138.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"12","key":"871_CR43","doi-asserted-by":"publisher","first-page":"e70285","DOI":"10.1002\/hsr2.70285","volume":"7","author":"S Haumba","year":"2024","unstructured":"Haumba S, Arora S, Williams V, Maseko T, Mafukidze A, Ojoo S. Prevalence, Predictors, and Outcomes of HIV Care in HIV-Positive Clients Entering HIV Care with Advanced HIV Disease in Sub\u2010Saharan Africa 2010\u20132022: Systematic Review and Meta\u2010Analysis. Health Sci Rep. 2024;7(12):e70285.","journal-title":"Health Sci Rep"},{"issue":"7","key":"871_CR44","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/cid\/ciu1137","volume":"60","author":"MJ Siedner","year":"2015","unstructured":"Siedner MJ, Ng CK, Bassett IV, Katz IT, Bangsberg DR, Tsai AC. Trends in CD4 count at presentation to care and treatment initiation in sub-Saharan Africa, 2002\u20132013: a meta-analysis. Clin Infect Dis Off Publ Infect Dis Soc Am. 2015;60(7):1120\u20137.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"871_CR45","doi-asserted-by":"crossref","unstructured":"Gunda DW, Nkandala I, Kilonzo SB, Kilangi BB, Mpondo BC. Prevalence and Risk Factors of Mortality among Adult HIV Patients Initiating ART in Rural Setting of HIV Care and Treatment Services in North Western Tanzania: A Retrospective Cohort Study. J Sex Transm Dis. 2017; 2017:1\u20138.","DOI":"10.1155\/2017\/7075601"},{"key":"871_CR46","doi-asserted-by":"publisher","first-page":"1187274","DOI":"10.3389\/fpubh.2023.1187274","volume":"11","author":"L Mugenyi","year":"2023","unstructured":"Mugenyi L, Hansen CH, Mayaud P, Seeley J, Newton R, Nanfuka M, et al. Effect of the universal test and treat policy on the characteristics of persons registering for HIV care and initiating antiretroviral therapy in Uganda. Front Public Health. 2023;11:1187274.","journal-title":"Front Public Health"},{"issue":"1","key":"871_CR47","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12981-022-00447-2","volume":"19","author":"S Opoku","year":"2022","unstructured":"Opoku S, Sakyi SA, Ayisi-Boateng NK, Enimil AK, Senu E, Ansah RO, et al. Factors associated with viral suppression and rebound among adult HIV patients on treatment: a retrospective study in Ghana. AIDS Res Ther. 2022;19(1):21.","journal-title":"AIDS Res Ther"},{"issue":"1","key":"871_CR48","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1186\/s12889-023-16453-6","volume":"23","author":"D Fernandez","year":"2023","unstructured":"Fernandez D, Ali H, Pals S, Alemnji G, Vasireddy V, Siberry GK, et al. Assessing sex differences in viral load suppression and reported deaths using routinely collected program data from PEPFAR-supported countries in sub-Saharan Africa. BMC Public Health. 2023;23(1):1941.","journal-title":"BMC Public Health"},{"issue":"04","key":"871_CR49","doi-asserted-by":"publisher","first-page":"178","DOI":"10.4236\/wja.2023.134015","volume":"13","author":"EW Isaac","year":"2023","unstructured":"Isaac EW, Ajani A, Manga M, Difa AJ, Oluwaseun OC, Danlami MH. Virologic Response among Children and Adults in an Antiretroviral Therapy Programme in Northern Nigeria: A Cross-Sectional Descriptive Study. World J AIDS. 2023;13(04):178\u201392.","journal-title":"World J AIDS"},{"issue":"1","key":"871_CR50","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2458-13-38","volume":"13","author":"F Mosha","year":"2013","unstructured":"Mosha F, Muchunguzi V, Matee M, Sangeda RZ, Vercauteren J, Nsubuga P, et al. Gender differences in HIV disease progression and treatment outcomes among HIV patients one year after starting antiretroviral treatment (ART) in Dar es Salaam, Tanzania. BMC Public Health. 2013;13(1):38.","journal-title":"BMC Public Health"},{"key":"871_CR51","doi-asserted-by":"publisher","unstructured":"Novelli S, Delobel P, Bouchaud O, Avettand-Fenoel V, Fialaire P, Cabi\u00e9 A et al. Enhanced immunovirological response in women compared to men after antiretroviral therapy initiation during acute and early HIV\u20101 infection: results from a longitudinal study in the French ANRS Primo cohort. J Int AIDS Soc. 2020. https:\/\/onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1002\/jia2.25485. Accessed 1 May 2025.","DOI":"10.1002\/jia2.25485"},{"issue":"12","key":"871_CR52","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1097\/QAD.0000000000002603","volume":"34","author":"K El Bouzidi","year":"2020","unstructured":"El Bouzidi K, Jose S, Phillips AN, Pozniak A, Ustianowski A, Gompels M, et al. First-line HIV treatment outcomes following the introduction of integrase inhibitors in UK guidelines. AIDS. 2020;34(12):1823\u201331.","journal-title":"AIDS"},{"issue":"7","key":"871_CR53","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1001\/jama.2024.24543","volume":"333","author":"RT Gandhi","year":"2025","unstructured":"Gandhi RT, Landovitz RJ, Sax PE, Smith DM, Springer SA, G\u00fcnthard HF, et al. Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society\u2013USA Panel. JAMA. 2025;333(7):609.","journal-title":"JAMA"},{"issue":"2","key":"871_CR54","doi-asserted-by":"publisher","first-page":"e085169","DOI":"10.1136\/bmjopen-2024-085169","volume":"15","author":"HE Hareru","year":"2025","unstructured":"Hareru HE, Ashuro Z, Debela BG, Sisay D, Ashenafi E, Abebe M, et al. Satisfaction with HIV\/AIDS treatment and care services and their associated factors among adult people receiving antiretroviral therapy in Ethiopia: a systematic review and meta-analysis. BMJ Open. 2025;15(2):e085169.","journal-title":"BMJ Open"},{"issue":"1","key":"871_CR55","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12879-019-4732-6","volume":"20","author":"AA Desta","year":"2020","unstructured":"Desta AA, Woldearegay TW, Futwi N, Gebrehiwot GT, Gebru GG, Berhe AA, et al. HIV virological non-suppression and factors associated with non-suppression among adolescents and adults on antiretroviral therapy in northern Ethiopia: a retrospective study. BMC Infect Dis. 2020;20(1):4.","journal-title":"BMC Infect Dis"},{"key":"871_CR56","doi-asserted-by":"publisher","unstructured":"Rolle CP, Nguyen V, Hinestrosa F, DeJesus E. Virologic outcomes of switching to dolutegravir functional mono- or dual therapy with a non-cytosine nucleoside analog: a retrospective study of treatment-experienced patients living with HIV. AIDS Res Ther. 2021. https:\/\/aidsrestherapy.biomedcentral.com\/articles\/https:\/\/doi.org\/10.1186\/s12981-021-00352-0. Accessed 1 May 2025.","DOI":"10.1186\/s12981-021-00352-0"},{"issue":"19","key":"871_CR57","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1056\/NEJMoa1215541","volume":"369","author":"SL Walmsley","year":"2013","unstructured":"Walmsley SL, Antela A, Clumeck N, Duiculescu D, Eberhard A, Guti\u00e9rrez F, et al. Dolutegravir plus Abacavir\u2013Lamivudine for the Treatment of HIV-1 Infection. N Engl J Med. 2013;369(19):1807\u201318.","journal-title":"N Engl J Med"},{"key":"871_CR58","doi-asserted-by":"crossref","unstructured":"Mehari EA, Muche EA, Gonete KA. Virological Suppression and Its Associated Factors of Dolutegravir-Based Regimen in a Resource-Limited Setting: An Observational Retrospective Study in Ethiopia. Volume 13. HIVAIDS Auckl, NZ.; 2021. pp. 709\u201317.","DOI":"10.2147\/HIV.S316776"},{"key":"871_CR59","doi-asserted-by":"crossref","unstructured":"Das S, Taha H, Das A. Clinical effectiveness of dolutegravir in the treatment of HIV\/AIDS. Infect Drug Resist. 2015;339.","DOI":"10.2147\/IDR.S68396"},{"key":"871_CR60","doi-asserted-by":"publisher","first-page":"491","DOI":"10.2147\/HIV.S422173","volume":"15","author":"TG Guyo","year":"2023","unstructured":"Guyo TG, Toma TM, Haftu D, Kote M, Merid F, Kulayta K, et al. Proportion of Attrition and Associated Factors Among Children Receiving Antiretroviral Therapy in Public Health Facilities, Southern Ethiopia. HIVAIDS - Res Palliat Care. 2023;15:491\u2013502.","journal-title":"HIVAIDS - Res Palliat Care"},{"key":"871_CR61","doi-asserted-by":"crossref","unstructured":"Gemechu GB, Hebo H, Kura Z. Children\u2019s Adherence to Antiretroviral Therapy and Associated Factors: Multicenter Cross-Sectional Study. HIVAIDS - Res Palliat Care 2023; Volume 15:423\u201334.","DOI":"10.2147\/HIV.S407105"},{"issue":"3","key":"871_CR62","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/QAD.0000000000001312","volume":"31","author":"S Shiau","year":"2017","unstructured":"Shiau S, Strehlau R, Technau KG, Patel F, Arpadi SM, Coovadia A, et al. Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants. AIDS. 2017;31(3):355\u201364.","journal-title":"AIDS"},{"key":"871_CR63","doi-asserted-by":"crossref","unstructured":"Afrane AKA, Goka BQ, Renner L, Yawson AE, Alhassan Y, Owiafe SN et al. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment center in Southern Ghana: a cross-sectional study. BMC Infect Dis. 2021. 21(1).","DOI":"10.1186\/s12879-021-06459-z"},{"key":"871_CR64","doi-asserted-by":"crossref","unstructured":"Mwau M, Syeunda CA, Adhiambo M, Bwana P, Kithinji L, Mwende J et al. Scale-up of Kenya\u2019s national HIV viral load program: Findings and lessons learned. Charpentier C, editor. PLOS ONE. 2018;13(1): e0190659.","DOI":"10.1371\/journal.pone.0190659"},{"key":"871_CR65","doi-asserted-by":"crossref","unstructured":"Bulage L, Ssewanyana I, Nankabirwa V, Nsubuga F, Kihembo C, Pande G et al. Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014\u2013July 2015. BMC Infect Dis. 2017. 17(1).","DOI":"10.1186\/s12879-017-2428-3"},{"key":"871_CR66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13031-018-0146-0","volume":"12","author":"JB Farhat","year":"2018","unstructured":"Farhat JB, Blanchet K, Bjertrup PJ, et al. Syrian refugees in Lebanon: the impact of conflict on HIV treatment continuity and viral load suppression. Confl Health. 2018;12:9.","journal-title":"Confl Health"},{"key":"871_CR67","volume-title":"United Nations High Commissioner for Refugees. HIV in humanitarian emergencies: operational guidelines","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. United Nations High Commissioner for Refugees. HIV in humanitarian emergencies: operational guidelines. Geneva: World Health Organization; 2016."}],"container-title":["AIDS Research and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12981-026-00871-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00871-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12981-026-00871-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:36:27Z","timestamp":1777329387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12981-026-00871-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["871"],"URL":"https:\/\/doi.org\/10.1186\/s12981-026-00871-8","relation":{},"ISSN":["1742-6405"],"issn-type":[{"value":"1742-6405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}